Published In
Turkish Journal of Gastroenterology
Volume 31 · Issue 3
Pages: 239-245
History
Published Online: March 15, 2020
Copyright © 2020 Tansu Yamazhan, İlker Turan, Galip Ersöz, Fulya Günşar, Hüsnü Pullukçu, Nilay Danış, Nalan G. Ünal, Rukiye Vardar, Nevin Oruç, Fatih Tekin, Meltem Taşbakan, Oğuz R. Sipahi, Ulus S. Akarca
Tansu Yamazhan
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
İlker Turan
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Galip Ersöz
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Fulya Günşar
Departments of Gastroenterology, Ege University School of Medicine, İzmir
Hüsnü Pullukçu
Department of Infectious Disease, Ege University, İzmir, Turkey
Nilay Danış
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Nalan G. Ünal
Department of Gastroenterology, Ege University, İzmir, Turkey
Rukiye Vardar
Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey
Nevin Oruç
Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey
Fatih Tekin
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Meltem Taşbakan
Liver Transplantation Department of Organ Transplantation and Research Center, Ege University School of Medicine, İzmir, Turkey
Oğuz R. Sipahi
Department of Infectious Disease, Ege University, İzmir, Turkey
Ulus S. Akarca
Ege Universitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı
Yamazhan, T., Turan, İlker, Ersöz, G., Günşar, F., Pullukçu, H., Danış, N., … Akarca, U. S. (2020). Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. Turkish Journal of Gastroenterology, 31(3), 239–245. https://doi.org/10.5152/tjg.2020.19076
Full Text
Full Text PDF
Full Text PDF
Abstract
Background/Aims: Ledipasvir (LDV) and sofosbuvir (SOF) as single-tablet regimen (STR) has been approved for treatment of chronic HCV infection (CHC) for treatment-naïve or experienced cirrhotic or non-cirrhotic patients. Our aim was to analyse the effectiveness and safety of 12-24 weeks treatment of LDV/SOF (90mg/400 mg)±ribavirin in a real-life setting in Turkey.
Materials and Methods: Between May-Dec 2016, 104 treatment-naïve or experienced adult patients with CHC and with or without cirrhosis (including decompensated cirrhosis) were included in this observational study. Patients were administered LDV/SOF STR± ribavirin once daily for 12 -24 weeks. SVR12 rates and effects of the baseline characteristics on SVR12 rates were assessed.
Results: Out of 104 enrolled patients (61.5% female, mean age 62.0 years); 60.6% were cirrhotic, 76.0% previously used peg-IFN, 94.2% had GT1. At the end of the treatment, 77.8% (77/99, no data for 21 patients) had undetectable HCV-RNA and 98.9% (94/95) had SVR12. In the baseline characteristics subgroups, the SVR12 rates varied between 94.4% and 100%, and none of the baseline characteristics had a significant effect on the SVR12 rates. During the study, 6 (5.8%) patients died and none of the deaths was suspected to be related to the LDV/SOF. No treatment-emergent adverse event was reported.
Conclusion: In conclusion, LDV/SOF±ribavirin yielded very high SVR12 rates, without any safety or tolerability concern in Turkey. The effectiveness of the LDV/SOF treatment was not affected by the patient demographics or medical characteristics such as fibrosis level, cirrhosis status, previous treatment status, HCV-RNA level or HCV genotype.
Most read articles by the same author(s)
- Nilay Danış, Hüseyin Döngelli, Tarkan Ünek, Aylin Bacakoğlu, İlker Turan, Abdullah Zeki Karasu, Fulya Günşar, Elvan Işık, Muhsin Murat Harputluoglu, Kutay Sağlam, Sezai Yılmaz, Bilger Çavuş, Sabahattin Kaymakoglu, Haydar Adanır, Dinç Dinçer, Derya Arı, Meral Akdogan Kayhan, Dilara Turan Gokce, Gökhan Kabacam, Sedat Karademir, Murat Kıyıcı, Selcan Cesur, Hale Gokcan, Zeynep Melekoglu Ellik, Ramazan İdilman, Murat Dayangaç, Yasemin Balaban, Ahmet Bulent Dogrul, Hilmi Anıl Dinçer, Gupse Adalı, Feyza Dilber, Murat Taner Gulsen, Orhan Sezgin, Zekiye Nur Harput, Murat Akyıldız, Kenan Moral, Tufan Egeli, Cihan Ağalar, Mücahit Özbilgin, Mesut Akarsu, De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes , Turkish Journal of Gastroenterology: Vol. 37 No. 4 (2026): Turkish Journal of Gastroenterology
- Deniz Öğütmen Koç, Göksel Bengi, Özlem Gül, Yeşim Özen Alahdab, Engin Altıntaş, Sezgin Barutçu, Yılmaz Bilgiç, Birol Bostancı, Mehmet Cindoruk, Kadri Çolakoğlu, Deniz Duman, Nergiz Ekmen, Ahmet Tarık Eminler, Yasemin Gökden, Süleyman Günay, Gözde Derviş Hakim, Kader Irak, Sabite Kacar, İsmail Hakkı Kalkan, Elmas Kasap, Aydın Şeref Köksal, Sedef Kuran, Nevin Oruç, Osman Özdoğan, Burak Özşeker, Erkan Parlak, Murat Saruç, İlker Şen, Gürhan Şişman, Mukaddes Tozlu, Nurettin Tunç, Nalan Gülşen Ünal, Hakan Ümit Ünal, Serkan Yaraş, Abdullah Emre Yıldırım, Müjde Soytürk, Dilek Oğuz, Orhan Sezgin, Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report , Turkish Journal of Gastroenterology: Vol. 35 No. Supplement 1 (2024): Turkish Journal of Gastroenterology
- İlker Turan, Özden Dedeli, Serhat Bor, Tankut İlter, Effects of a kefir supplement on symptoms, colonic transit, and bowel satisfaction score in patients with chronic constipation: A pilot study , Turkish Journal of Gastroenterology: Vol. 25 No. 6 (2014): Turkish Journal of Gastroenterology
- Tansu Yamazhan, Esra Zerdali, Yusuf Önlen, Selma Tosun, Özgür Günal, Ayşe Batırel, İmran Hasanoğlu, Tuba Turunç, Umay Balcı, Sibel Yıldız Kaya, Oğuz Karabay, İlknur Esen Yıldız, Lütfiye Nilsun Altunal, Hacer Deniz Özkaya, Selçuk Kaya, Ayşe İnci, Sevil Alkan, Dilek Sevgi Yıldız, Tayibe Bal, Esma Aslıhan Aydemir, Nurullah Eser, Serhat Uysal, Oğuzhan Acet, Fehmi Tabak, Rahmet Güner, A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate , Turkish Journal of Gastroenterology: Vol. 37 No. 2 (2026): Turkish Journal of Gastroenterology
- Orhan Sezgin, Serkan Yaraş, Mehmet Cindoruk, Elmas Kasap, Hakan Ünal, Aydın Şeref Köksal, Abdullah Emre Yıldırım, Burak Özşeker, Nevin Oruç, Müjde Soytürk, Sabite Kaçar, Muhsin Kaya, Kader Irak, Yasemin Gökden, Deniz Öğütmen Koç, Osman Özdoğan, Engin Altıntaş, Nergiz Ekmen, Murat Saruç, Şencan Acar, Mahmut Polat, Sezgin Barutçu, Göksel Bengi, Volkan Gökbulut, Nalan Gülşen Ünal, Dilek Oğuz, Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study , Turkish Journal of Gastroenterology: Vol. 35 No. 3 (2024): Turkish Journal of Gastroenterology
- Bülent Değertekin, Mehmet Demir, Ulus S. Akarca, Haluk Tarık Kani, Enver Üçbilek, Emre Yıldırım, Fatih Güzelbulut, Ayhan Balkan, Sezgin Vatansever, Nilay Danış, Melek Demircan, Aliye Soylu, Serkan Yaras, Aysun Kartal, Ayşe Kefeli, Feyza Gündüz, Kendal Yalçın, Elife Erarslan, Murat Aladağ, Murat Harputluoğlu, Ayşegül Özakyol, Tuncer Temel, Mesut Akarsu, Hale Sümer, Mete Akın, Bülent Albayrak, İlker Sen, Hüseyin Alkım, Ahmet Uyanıkoğlu, Kader Irak, Sinem Öztaşkın, Çağrı Burak Uğurlu, Şevkican Güneş, Selim Gürel, Kenan Nuriyev, İsmail İnci, Sabite Kaçar, Dinç Dinçer, Levent Doğanay, Hüseyin Savaş Göktürk, Ali Mert, Arif Mansur Coşar, Hakan Dursun, Roni Atalay, Sabiye Akbulut, Yasemin Balkan, Hayrettin Koklu, Halis Şimşek, Osman Özdoğan, Mehmet Çoban, Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience , Turkish Journal of Gastroenterology: Vol. 31 No. 12 (2020): Turkish Journal of Gastroenterology
- Müjde Soytürk, Göksel Bengi, Dilek Oğuz, İsmail Hakkı Kalkan, Mehmet Yalnız, Mustafa Tahtacı, Kadir Demir, Elmas Kasap, Nevin Oruç, Nalan Gülşen Ünal, Orhan Sezgin, Osman Özdoğan, Engin Altıntaş, Serkan Yaraş, Erkan Parlak, Aydın Şeref Köksal, Murat Saruç, Hakan Ünal, Belkıs Ünsal, Süleyman Günay, Deniz Duman, Alper Yurçi, Sabite Kacar, Levent Filik, Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report , Turkish Journal of Gastroenterology: Vol. 31 No. Supplement 1 (2020): Turkish Journal of Gastroenterology
- Enver Üçbilek, Abdullah Emre Yıldırım, Zeynep Ellik, İlker Turan, Büşra Haktanıyan, Berk Orucu, Mehmet Demir, Mukaddes Tozlu, Nimet Yılmaz, Yasemin Balaban, Ahmet Uyanıkoğlu, Mesut Akarsu, Ramazan Yolaçan, Orhan Sezgin, Kendal Yalçın, Murat Aladağ, Bilal Toka, Ayşe Kefeli, Aslı Örmeci, Alper Yurçi, Sami Fidan, Genco Gençdal, Ufuk Avcıoğlu, Ayhan Hilmi Çekin, Berat Ebik, Eylem Karatay, Murat Akyıldız, Aydın Şeref Köksal, Osman C. Özdoğan, Zeki Karasu, Ramazan Idilman, Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study , Turkish Journal of Gastroenterology: Vol. 35 No. 10 (2024): Turkish Journal of Gastroenterology
- Murat Toruner, Metin Basaranoglu, Ozlen Atug, Omer Senturk, Filiz Akyuz, Cem Cekic, Hulya Over Hamzaoglu, Fatih Tekin, Orhan Sezgin, Hale Akpinar, Aykut Ferhat Celik, Ahmet Tezel, Huseyin Savas Gokturk, Taylan Kav, Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey , Turkish Journal of Gastroenterology: Vol. 33 No. 5 (2022): Turkish Journal of Gastroenterology
- Ersan Özaslan, Fulya Günşar, Aslı Çiftçibaşı Örmeci, İbrahim Hatemi, Cumali Efe, Gülen Akyol, Nesrin Turhan, Funda Yılmaz Barbet, Özgül Sağol, Çiğdem Ataizi Çelikel, Mine Güllüoğlu, Dilara Turan Gökçe, Zülal İstemihan, Tuğçe Eşkazan, Ramazan İdilman, Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver , Turkish Journal of Gastroenterology: Vol. 34 No. Supplement 3 (2023): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 31 · Issue 3
Pages
239-245
History
Published Online
March 15, 2020
Copyright
Copyright (c) 2020 Tansu Yamazhan, İlker Turan, Galip Ersöz, Fulya Günşar, Hüsnü Pullukçu, Nilay Danış, Nalan G. Ünal, Rukiye Vardar, Nevin Oruç, Fatih Tekin, Meltem Taşbakan, Oğuz R. Sipahi, Ulus S. Akarca
Affiliations
Tansu Yamazhan
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
İlker Turan
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Galip Ersöz
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Fulya Günşar
Departments of Gastroenterology, Ege University School of Medicine, İzmir
Hüsnü Pullukçu
Department of Infectious Disease, Ege University, İzmir, Turkey
Nilay Danış
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Nalan G. Ünal
Department of Gastroenterology, Ege University, İzmir, Turkey
Rukiye Vardar
Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey
Nevin Oruç
Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey
Fatih Tekin
Department of Gastroenterology, Ege University School of Medicine, İzmir, Turkey
Meltem Taşbakan
Liver Transplantation Department of Organ Transplantation and Research Center, Ege University School of Medicine, İzmir, Turkey
Oğuz R. Sipahi
Department of Infectious Disease, Ege University, İzmir, Turkey
Ulus S. Akarca
Ege Universitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı
Cite this Article
Yamazhan, T., Turan, İlker, Ersöz, G., Günşar, F., Pullukçu, H., Danış, N., … Akarca, U. S. (2020). Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. Turkish Journal of Gastroenterology, 31(3), 239–245. https://doi.org/10.5152/tjg.2020.19076
Outlines